Diseases of the pericardium commonly manifest in one of three ways: acute pericarditis, pericardial effusion and constrictive pericarditis. In the developed world, the most common cause of acute pericarditis is viral or idiopathic disease, while in the developing world tuberculous aetiology, particularly in subSaharan Africa, is commonplace owing to the high prevalence of HIV. This article provides an approach to the diagnosis, investigation and management of these patients.
CME
Pericardial diseases are rela tively common in clinical practice, presenting in one of three ways: pericarditis (which may recur or become chronic), pericardial effusion with or without peri cardial tamponade and constrictive peri carditis. Less common manifestations include pericardial cysts and neoplasms. A variety of aetiologies (Table 1) are implicated in peri cardial disease, and establishing a definitive diagnosis is challenging, as the yield of diag nostic tests is relatively low. [1] The incidence of acute pericarditis is 27.7/100 000 cases in the developed world and accounts for 5% of emergency room admissions for chest pain. [2, 3] Viral infection is responsible for the majority of cases in the developed world, while in the developing world Myco bacterium tuberculosis, particularly with HIV coinfection in subSaharan Africa, remains prevalent. [4, 5] A paucity of randomised data exists in the field of pericardial disease; however, more recently multicentre randomised trials have defined the role of colchicine in acute and recurrent pericarditis and that of steroid therapy in tuberculous pericarditis.
[68] This review focuses predominantly on an approach to acute pericarditis commonly encountered at primary care level, and offers brief insights into effusive disease and constriction.
An approach to pericarditis
The following is a stepwise approach to acute pericarditis:
• Presenting symptoms and signs.
• Appropriate special investigations.
• When to consider hospital admission.
• Evidencebased medical therapy and assesss ing for a response.
• Prognosis.
• Recurrent pericarditis.
Presenting symptoms and signs
Positional pleuritic chest pain, improved by sitting forward and exacerbated by deep inspi ration, is present in >85 90% of cases. [3] Radiation of pain to the trapezius ridge is virtually pathognomonic of pericarditis, as the phrenic nerve that innervates these muscles traverses the pericardium. [9] Prodromal symp toms of a viral illness may be present and constitutional symptoms of tuberculosis (TB) should be sought. Sinus tachycardia and lowgrade fever are common, while a temperature >38 o C suggests a specific cause of pericarditis. A triphasic pericardial friction rub is audible in approximately onethird of cases, best heard with the diaphragm of the stethoscope over the left lateral sternal border with the patient leaning forward (Audio 1). [3] This can be transient and frequent evaluation for its presence is useful as it is highly specific for the disease.
Signs of an underlying systemic inflam matory disease may point to a specific cause, e.g. systemic lupus erythematosus with a pericardial serositis.
A clinical diagnosis of pericarditis can be established when two of the following cri teria are present: [3] • Pericarditic chest pain.
• Pericardial friction rub.
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Appropriate special investigations
The following are recommended in all patients with suspected pericarditis: a 12 lead ECG, a chest radiograph, inflam matory markers and a transthoracic echocardio gram. [10] A 12-lead ECG is the first-line investigation • Typical ECG findings are found in up to 60% of patients, are highly variable between different patients and are influenced by therapy. [11] • They include ( Fig. 1 ):
• Widespread saddleshaped (concave upward) STsegment eleva tion not confined to a single coronary territory with reciprocal ST depression in aVR.
• Inferior and precordial PRsegment depression with PRsegment elevation in aVR -the discordant STPR segment sign. This is more specific for pericarditis than diffuse ST elevation alone. [12] • Sinus tachycardia.
• Q waves may be present in postmyocardial infarction (MI) peri carditis. Both early and late (Dressler's syndrome) manifest ations are rare in the era of reperfusion therapy; they may however occur after a silent MI or a missed infarct.
• Ultimately the ST and PR segments normalise, which may be followed by widespread Twave inversion.
• The most important differential diagnosis is that of an STelevation acute coronary syndrome. This necessitates a thorough evaluation of the nature of the chest pain and the morphology and distribution of ST elevation on ECG.
Chest radiograph
• Features of pleuropulmonary disease may point to a specific aetiology, e.g. TB.
[13]
• The cardiac silhouette only increases when >300 mL of pericardial fluid has collected and is therefore commonly normal in acute pericarditis. [14] Laboratory tests • Inflammatory markers: Creactive protein (CRP), or erythrocyte sedimentation rate (ESR) where CRP is not available, and a white cell count should be undertaken in all cases. Elevations are supportive of a diagnosis of acute pericarditis and are valuable for monitoring disease activity and response to therapy. [15] • Troponins may be elevated in patients with associated myocarditis. [16] • Given its high prevalence in subSaharan Africa, TB should always be considered as a possible cause. Constitutional symp toms of TB and/or radiological evidence of the disease mandate further workup. A high index of suspicion for TB must be maintained in patients from a disadvantaged socioeconomic setting. [17] • Retroviral serology and serum creatinine level determination should be undertaken routinely.
• Routine serological markers for connective tissue disease are not indicated in lowrisk cases; neither is routine viral serology as it has a low yield and does not alter manage ment. [1] • A more detailed search for a specific cause is undertaken in patients requiring hospital admission or who fail a trial of medical therapy.
Transthoracic echocardiogram (TTE)
• An associated pericardial effusion, its haemodynamic effects and possible myo carditis can be evaluated via TTE.
• TTE is recommended in all patients. [10] However, in underresourced areas it would not be unreasonable to limit it to patients requiring hospital admission or in whom a specific aetiology is suspected.
Cardiac magnetic resonance and cardiac computed tomography CMR can more accurately delineate pericardial inflammation by means of pericardial late gadolinium enhancement. [13] Cardiac CT also offers a more accurate assessment of peri cardial thickness than TTE, at the expense of exposure to ionising radiation. Neither of these adjunctive imaging modalities take preference over TTE as a firstline investigation. Their value is in the rare setting where a high clinical suspicion of pericarditis exists, yet the clinical diagnostic criteria remain unmet. [13] When to consider hospital admission High-risk cases [18] Hospital admission is required when a specific aetiology is suspected or when ≥1 of the following poor prognostic features are present:
• Temperature >38°C.
• Subacute onset.
• Large pericardial effusion (diastolic echo free space >20 mm) with or without cardiac tamponade.
• Myopericarditis.
• Traumatic pericarditis.
• Chronic oral anticoagulant or immuno suppressive therapy.
• Failure to respond to at least 1 week of aspirin or nonsteroidal antiinflam matory drug (NSAID) therapy.
A more detailed workup, including evalua tion for TB, connective tissue disease and metabolic diseases, is required. When a specific cause is identified, therapy aimed at the underlying cause is indicated.
Evidence-based medical therapy and assessing for a response
• Lowrisk patients, in whom no specific cause is suspected and who do not have predictors of a poor prognosis, can be managed as outpatients. [10] It would not be unreason able to limit TTE in this group to those who fail to respond to 1 week of anti inflammatory therapy, particularly when managed at primary healthcare level.
• Restriction of physical activity is recommended until symptoms resolve and the CRP normalises. In athletes, a restrict ion of athletic activity for at least 3 months is advised, provided the CRP, ECG and TTE have returned to normal at the end of this period. [10] In suspected myopericarditis 
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(elevated troponin level) athletic activity should be avoided for 6 months. [10] • Firstline medical therapy includes aspirin or NSAIDs and colchicine. [6, 7] Gastro protection, preferably proton pump inhi bitors, should be provided (Table 2 ).
• Antiinflammatory therapy commonly provides abrupt sympto matic relief.
• Colchicine, added to aspirin or NSAID therapy, has been evaluated in two well conducted, placebocontrolled, randomised clinical trials, where it has been shown to improve the response to medical therapy and prevent recurrences. [6, 7] • Corticosteroids are associated with the evolution of acute pericarditis into a chronic, recurrent disease and are therefore not indicated as firstline therapy. [10] They are considered when NSAIDs or aspirin are contraindicated or have failed to provide a response, and an infective aetiology has been excluded. Alternatively, they are indicated when a specific cause mandates their use, such as connective tissue disease. When indicated for idiopathic disease, they should be used at a lowtomoderate dose together with colchicine and tapered once the CRP has normalised (Table 2) . [10] • Lowrisk patients should be reevaluated after 1 week for a response. Those who fail to respond (persistent symptoms and/or elevated CRP) are considered to be moderate risk and require hospital admission and an aetiology search. Those who respond infrequently require >2 weeks of NSAID or aspirin therapy, while colchicine should be continued for 3 months (Table 2 ).
[10]
Prognosis
• Acute idiopathic or viral pericarditis has a good prognosis with a low complication rate. [19] • Cardiac tamponade and constrictive pericarditis are more commonly asso ciated with specific underlying aetio lo gies, particu larly TB and purulent peri carditis. [19] • Up to 30% of idiopathic cases can develop recurrent pericarditis, associated with considerable morbidity. [20] This risk can be halved by the administration of colchicine at the outset. [20] 
Recurrent pericarditis
• This is defined as a recurrence of peri carditis after a symptomfree period of 4 6 weeks after the initial illness. While up to 30% of patients may experience a recurrence after the index episode, the risk of a second recurrence may be as high as 50% in those not treated with colchicine, and even higher after corticosteroid administration. [20] • The most common cause for recurrent pericarditis is the inadequate treatment of an initial episode. [20] • A search for a potential underlying cause is required and referral for tertiary evaluation is recommended.
• In cases of idiopathic disease, treatment is similar to that for a first attack, except for an extended duration of therapy with both NSAIDs (weeks months) and weightad justed colchicine (≥6 months' duration). [20] • Corticosteroids remain secondline thera py owing to their risk for precipitating a chronic form of the disease.
• In patients who do not respond to anti inflammatory therapy or who require high maintenance doses of prednisone, azathio prine, intravenous immunoglobulin and anakinra (a recombinant inter leukin 1β receptor antagonist) have been attempted. [10] • As a last resort, after failed medical therapy, pericardiectomy may be required. [10] • Overall, the prognosis is good in that a case of constrictive pericarditis has never been attributed to idiopathic recurrent pericarditis. However, morbidity is high owing to persistent symptoms.
An approach to pericardial effusions
• In subSaharan Africa TB is responsible in >90% of HIVpositive and 50 70% of
HIVnegative patients who present with a large pericardial effusion. Emphasis must therefore be placed on excluding TB. [21] • The development of cardiac tamponade, a lifethreatening condi tion, is determined by the rate of fluid accumulation, pericardial compliance and position of a loculated collection. The rapid accumulation of 200 mL of fluid can lead to acute tamponade, whereas slow accumulation can be well tolerated owing to peri cardial distensibility. • Loculated collections situated over low pressure chambers, e.g. the right ventricle, can result in early haemodynamic compromise.
• The 12lead ECG may reveal smallvoltage QRS complexes with electrical alternans due to swinging of the heart within a large collection ( Fig. 2 and Video 1).
• Cardiac tamponade remains a clinical diagnosis. Clinical signs include:
• Tachycardia and elevated jugular venous pressure (JVP).
• Muffled heart sounds.
• Pulsus paradoxus (>10 mmHg inspira tory drop in systolic blood pressure).
• A TTE confirms the presence of an effusion, identifies the safest approach for needle aspiration and provides supportive evidence of associated haemodynamic compromise. Pericardiocentesis has a complication rate of 4 10%, depending on operator experience and procedural urgency. 
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'Blind' pericardiocentesis is discouraged and TTE or ultrasonographic guidance to determine the site and angle of puncture is recommended. [22] In underresourced areas, emergency pericardiocentesis in a haemodynamically unstable patient may be necessary without ultrasound guidance, provided the diagnosis of pericardial tampo nade is established as accurately as clinically possible.
• Ultrasound or TTE availability is also useful for confirming a puncture that is within the pericardial space and not a cardiac chamber or pleural cavity by the injection of agitated contrast saline bubbles (Video 2). [23] • All effusions should be evaluated for a specific underlying aetiology. If safely accessible, pericardiocentesis should be undertaken in a controlled environment by a skilled operator.
• A pericardial fluid adenosine deaminase level ≥35 U/L has a sensitivity and speci ficity of 89% and 74%, respectively, for the diagnosis of TB pericarditis. [24] Traditional diagnostic tests for pericardial TB are insensitive and require long culture periods. The organism is not identified in the pericardial fluid of 27 48% of cases and adenosine deaminase therefore remains an important biochemical diag nostic aid. [24, 25] • In our local experience complete percuta neous drainage of a tuberculous effusion, in combination with antituber culous therapy, is associated with an extremely low risk for constriction and cardiac death. [25] One small trial has shown that the addition of intrapericardial uro kinase may facilitate this approach. [26] The administration of intrapericardial steroids did not influence the risk of developing constriction in an underpowered trial of 57 patients. [27] However, more recently adjunc tive oral steroid therapy has been shown to reduce the risk of constriction in both HIVpositive and negative patients. [8] In this trial a definite diagnosis of TB pericarditis was established in 16.7% of participants. High dose oral prednisone did not translate into a mortality benefit and was unfortunately associated with an increase in HIVrelated cancers in the HIVpositive group. [8] An approach to constrictive pericarditis
• Constriction is a form of diastolic heart failure that is potentially curable.
• The heart becomes encased in a rigid shell of pericardium, isolating it from the rest of the thoracic cavity.
• Respiratory changes in intrathoracic pres sure can therefore not be transmitted to the heart, leading to the two hallmark physiological features of constriction:
• dissociation of intrathoracic and intra cardiac pressures; and • enhanced ventricular interdependence ( Fig. 3 A and B , and Video 3).
• Establishing a clinical diagnosis is challen ging and the disease therefore often goes unrecognised until late in its course, when overt right heart failure develops.
• A high index of suspicion is required in patients who have had prior TB, cardiac Fig. 3 (A) CME surgery, thoracic irradiation or pericarditis. TB remains the most important cause in South Africa. [8] • Symptoms range from a change in effort tolerance to those of predominant right heart failure.
• Clinical signs may be subtle and careful evaluation for their presence is required:
• A raised JVP with rapid ydescents (Video 4). The JVP may be raised to a point within the cranium at a recumbent level of 45° and may therefore not be visible. The level of elevation often only becomes apparent in the upright position. • Kussmaul's sign -paradoxical inspira tory elevation of the JVP.
• Diastolic apex beat.
• A right ventricular pericardial knock (Audio 2).
• Ascites that is more prominent than the degree of peripheral oedema.
• A lateral chest radiograph can reveal pericardial calcification in up to 50% of patients with tuberculous constriction (Fig. 4 ).
• The clinical diagnosis can be confirmed by TTE, with tissue Doppler imaging aiding in both establishing the diagnosis and differentiating constriction from restrictive cardiomyopathy. An invasive left and right heart study is infrequently required, but is most useful to distinguish constriction from restrictive cardiomyopathy if doubt exists despite a detailed TTE.
• Early diagnosis leads to timelier referral for surgical pericardiectomy, thereby reducing perioperative mortality. This risk is as high as 15% in patients who already have a New York Heart Association class IV effort tolerance and/or hyponatraemia at the time of surgery. [28] 
